Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1992-09-17
1995-11-28
Warden, Jill
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530324, 530399, A61K 3830
Patent
active
054708281
ABSTRACT:
The invention provides peptide analogues of insulin-like growth factor-1 (IGF-1) or factor-2 (IGF-2). The peptide analogues of IGF-1 have at least the glutamic acid residue at position 3 replaced by another amino acid. The peptide analogues of IGF-2 are replaced at position 5 or 6 with another amino acid.
REFERENCES:
patent: 4876242 (1989-10-01), Applebaum
patent: 5164370 (1992-11-01), Ballard
Francis, G. L., Aplin, S. E., Milner, S. J. McNeil, K. A. Ballard, F. J. & Wallace, J. C. "Insulin-like growth factor (IGF-II) binding to IGF-binding proteins and IGF receptors is modified by deletion of the N-terminal hexapeptide or substitution of Arg for Glu.sup.6 in IGF-II: a comparison with the structurally equivalent analogues of IGF-I." Biochem, J. 293, 713-719 (1993).
Bagley et al., Biochem. J., 259, 665-671 (1989).
Bayne et al., Chemical Abstracts, 109, Abs. No. 17150r (1988).
Ballard et al., Biochem. and Biophys. Res. Commun., 149, 398-404 (1987).
Blumberg et al., Chemical Abstracts, 104, Abs. No. 203501c (1986).
Carlsson-Skwirut et al., Biochim. Biophys. Acta, 1011, 192-197 (1989).
Carlsson-Skwirut et al., Chemical Abstracts, 105, Abs. No. 36363w (1986).
Carlsson-Skwirut et al., Chemical Abstracts, 106, Abs. No. 96902b (1987).
Carlsson-Skwirut et al., FEBS, 201, 46-50 (1986).
Cascieri et al., Chemical Abstracts, 109, Abs. No. 86924h (1988).
Dawe et al., Chemical Abstracts, 108, Abs. No. 202006r (1988).
Fagerstedt et al., ACTA Endoctrinol, 103 (256), 216 (1983).
Francis et al., Chemical Abstracts, 108, Abs. No. 198502e (1988).
Merrifield, Angew. Chem. Int. Ed. Engl., 24, 799-810 (1985).
Nokihara et al., Chemical Abstracts, 97, Abs. No. 24215c (1982).
Rinderknecht et al., J. Biol. Chem., 253, 2769-2776 (1978).
Ross et al., Biochem J., 258, 267-272 (1989).
Rudinger, Peptide Hormones, (Parsons Ed.), University Park Press, 1-5 (1976).
Sara et al., Chemical Abstracts, 105, Abs. No. 73328j (1986).
Sara et al., Proc. Natl. Acad. Sci. USA, 78, 3175-3179 (1981).
Sara et al., Proc. Natl. Acad. Sci. USA, 83, 4904-4907 (1986).
Svoboda et al., Biochemistry, 19, 790-797 (1980).
Ballard Francis J.
Wallace John C.
Wells Julian R. E.
GroPep Pty. Ltd.
Lukton David
Warden Jill
LandOfFree
Peptide analogs of insulin-like growth factor II does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide analogs of insulin-like growth factor II, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide analogs of insulin-like growth factor II will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2013698